RESISTANCE TO HYPOXIC CONDUCTION BLOCK IN SCIATIC-NERVES OF RATS WITH STREPTOZOTOCIN-INDUCED DIABETES-MELLITUS

被引:14
作者
CALCUTT, NA [1 ]
ETTLINGER, CB [1 ]
CARRINGTON, AL [1 ]
DIEMEL, L [1 ]
TOMLINSON, DR [1 ]
机构
[1] UNIV LONDON,QUEEN MARY & WESTFIELD COLL,DEPT PHARMACOL,MILE END RD,LONDON E1 4NS,ENGLAND
关键词
DIABETES-MELLITUS; DIABETIC NEUROPATHY; HYPERGLYCEMIA; HYPOXIA; INSULIN; ISCHEMIA; NERVE CONDUCTION;
D O I
10.1016/0022-510X(91)90294-H
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This study describes the electrophysiological responses of endoneurial preparations derived from rat sciatic nerve to acute hypoxia in vitro. Preparations from control rats exhibited a marked decline in compound action potential (CAP) amplitude coupled with an increase in latency, during 40 minutes exposure to 8% O2. In contrast, preparations from 4 week streptozotocin-diabetic rats showed a greatly reduced decline in CAP amplitude, with an increase in latency. Twice-daily insulin treatment of diabetic rats results in a pattern of CAP amplitude decline that initially resembled that of untreated diabetics but by 40 min was similar to controls, with latency again increasing during hypoxia. Nerves were also maintained in 25 mmol/l glucose, rather than the 5 mmol/l glucose of the above studies. Under such conditions the performance of nerves from diabetic rats was unaltered. Nerves from control rats exhibited an initial resistance to hypoxia but by 40 min CAP had declined to values of control rats maintained in 5 mmol/l glucose. An increase in latency during hypoxia was also noted in preparations from control or diabetic rats maintained in 25 mmol/l glucose. The maintenance of CAP amplitude during hypoxia by diabetic preparations in initially related to increased substrate availability, with an additional component that is not related to external glucose levels in vitro, and is absent after insulin treatment of diabetic rats.
引用
收藏
页码:116 / 123
页数:8
相关论文
共 32 条
[1]   HIGH-DOSE DIETARY MYOINOSITOL SUPPLEMENTATION DOES NOT ALTER THE ISCHEMIA PHENOMENON IN HUMAN DIABETICS [J].
ARENDRUP, K ;
GREGERSEN, G ;
HAWLEY, J ;
HAWTHORNE, JN .
ACTA NEUROLOGICA SCANDINAVICA, 1989, 80 (02) :99-102
[2]   GANGLIOSIDE TREATMENT OF DIABETIC RATS - EFFECTS ON NERVE ADENOSINE-TRIPHOSPHATASE ACTIVITY AND MOTOR-NERVE CONDUCTION-VELOCITY [J].
CALCUTT, NA ;
TOMLINSON, DR ;
WILLARS, GB .
LIFE SCIENCES, 1988, 42 (16) :1515-1520
[3]  
DYCK PJ, 1989, NEW ENGL J MED, V320, P57
[4]   EFFECTS OF INSULIN AND DIETARY MYOINOSITOL ON IMPAIRED PERIPHERAL MOTOR-NERVE CONDUCTION-VELOCITY IN ACUTE STREPTOZOTOCIN DIABETES [J].
GREENE, DA ;
DEJESUS, PV ;
WINEGRAD, AI .
JOURNAL OF CLINICAL INVESTIGATION, 1975, 55 (06) :1326-1336
[5]   EFFECTS OF ACUTE EXPERIMENTAL DIABETES ON COMPOSITE ENERGY-METABOLISM IN PERIPHERAL-NERVE AXONS AND SCHWANN-CELLS [J].
GREENE, DA ;
WINEGRAD, AI .
DIABETES, 1981, 30 (11) :967-974
[6]   RESISTANCE TO ISCHEMIC CONDUCTION FAILURE IN CHRONIC HYPOXEMIA AND DIABETES [J].
HAMPTON, KK ;
ALANI, SM ;
WILSON, JI ;
PRICE, DE .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (11) :1303-1305
[7]   RESISTANCE OF THE DIABETIC RAT NERVE TO ISCHEMIC INACTIVATION [J].
JARAMILLO, J ;
SIMARDDUQUESNE, N ;
DVORNIK, D .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1985, 63 (07) :773-777
[8]   MOTOR NERVE CONDUCTION VELOCITY IN DIABETES [J].
LAWRENCE, DG ;
LOCKE, S .
ARCHIVES OF NEUROLOGY, 1961, 5 (05) :483-&
[10]   ISCHEMIC CONDUCTION FAILURE AND ENERGY-METABOLISM IN EXPERIMENTAL DIABETIC NEUROPATHY [J].
LOW, PA ;
WARD, K ;
SCHMELZER, JD ;
BRIMIJOIN, S .
AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 248 (04) :E457-E462